Aichi, Japan

Hiroshi Shibuya

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Shibuya. Retrieved from https://idiyas.com/inventor/hiroshi-shibuya-qa3u7pg1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Shibuya: Innovator in Biomedicine

Introduction

Hiroshi Shibuya is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of biomedicine, particularly in the area of interleukin receptor research. His work has implications for understanding immune responses and developing therapeutic strategies.

Latest Patents

Hiroshi Shibuya holds a patent for an invention titled "IL-2R-associated polypeptide and DNA molecules coding therefor." This invention relates to a polypeptide, p, which is associated with the interleukin receptor (IL-R). It binds specifically to the β and γ subunits of IL-R and is further capable of binding NAD. The invention also includes nucleic acid molecules coding for p and antibodies that specifically bind to p. He has 1 patent to his name.

Career Highlights

Shibuya has had a distinguished career, working with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His research has contributed to advancements in therapeutic approaches for various diseases.

Collaborations

Throughout his career, Hiroshi Shibuya has collaborated with notable scientists, including Tadatsugu Taniguchi and Edward Leon Barsoumian. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Hiroshi Shibuya is a key figure in the field of biomedicine, with a focus on interleukin receptors. His innovative work continues to influence research and development in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…